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SUMMARY
Severe leptospirosis affects predominantly males and presents a high susceptibility to hypokalemic acute renal failure. As
hypokalemia and hyperkalemia induce severe complications, it is important to evaluate if the initial serum potassium is an independent
risk factor for death in leptospirosis. The medical records of 1016 patients hospitalized with the diagnosis of leptospirosis were
reviewed. The analysis was restricted to 442, according to the following criteria: male, 18 years or older, information about death or
hospital discharge and recorded values of serum potassium, serum creatinine and duration of symptoms at admission. Potassium
values lower than 3.5 mEq/L (hypoK), 3.5-5 mEq/L (normoK) and above 5 mEq/L (hyperK) were detected in 180, 245 and 17
patients, respectively. The death rate increased with serum potassium: 11.1% in the hypoK, 14.7% in the normoK and 47.1% in the
hyperK group (p = 0.002). In a logistic regression model (normoK as referent), including age, creatinine and duration of symptoms,
hypoK was not associated with increased death rate (odds ratio (OR) = 0.80; p > 0.1). On the other hand, hyperK showed a significant
association with increased risk of death (OR = 3.95, p = 0.021). In conclusion, in this sample of men with leptospirosis initial serum
potassium was positively and independently correlated with the risk of in-hospital death.
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INTRODUCTION
Leptospirosis is a worldwide zoonotic disease that affects
predominantly men2,9. The case-fatality rate is high, mainly among the
elderly, those with the icteric form of the disease, with severe acute renal
failure(ARF) and patients who start antibiotic treatment at the late stage of
the disease3,5,7,9. The renal involvement in leptospirosis is characterized by
acute interstitial nephritis that may be associated with acute tubular
necrosis4. Predisposition to hypokalemia is another particular feature of
the renal involvement in leptospirosis1. The presence of hypokalemia is
more common in patients with ARF due to leptospirosis than in patients
with ARF due to other causes1. A high frequency of ARF with normal or
increased urinary output and a defect in the renal tubules are factors that
have been related to hypokalemia in patients with leptospirosis1. As both
hypo and hyperkalemia induce severe complications it is important to
evaluate if the initial serum potassium is related to in-hospital death in
leptospirosis patients, taking into account the influence of other potential
risk factors. This study assesses whether serum potassium level at hospital
admission is independently associated with death in men with leptospirosis.
METHODS
This is a retrospective analysis using data abstracted from the medical
records of 1016 patients with leptospirosis admitted to the Couto Maia
Hospital (HCMaia), located in the city of Salvador, northeast Brasil,
between 1993 and 1997. The research protocol was approved by the
ethics committee of the HCMaia. Inclusion criteria were: being male
older than 17 years, with recorded data on serum potassium, duration of
symptoms and creatinine values at hospital admission and with
information about the outcome: death or hospital discharge. Leptospirosis
diagnosis was based on clinical, laboratory and epidemiological data
according to the World Health Organization (WHO) criteria6. Six clinical
findings (headache, fever, conjunctival suffusion, meningeal signs,
myalgia and jaundice), two laboratory alterations (albuminuria and
azotemia) and exposure to rats or contaminated water were used to
determine a probability score. All patients reached at least 26 points
according to the WHO criteria, a limit to define a case as having a high
probability of leptospirosis6.
The patients were divided into three groups according to their serum
potassium value: < 3.5 (hypoK), 3.5-5.0 (normoK) and >5 mEq/L
(hyperK). One-way analysis of variance (or its nonparametric equivalent
Kruskal-Wallis H) was used to compare quantitative variables across
the potassium groups. The t test for independent samples was used for
compare means between two groups. The chi-square test (or the Fisher’s
exact test) was used to compare proportions. Multivariate logistic
regression was used to adjust the association between case-fatality rate
and the serum potassium levels for age, serum creatinine and duration
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of symptoms attributed to leptospirosis at hospital admission. Age was
categorized as < 50 and ³ 50 years, creatinine as <1.5mg/dL (reference),
1.5-3.0 and >3.0mg/dL and duration of symptoms as <4, 4-6 and ³ 7
days. Statistical analysis was performed using the SPSS, version 6.010,11
for Windows, and the Computer Programs for Epidemiologists (PEPI),
version 38. P values below 0.05 were considered statistically significant.
RESULTS
Among 1016 cases with findings consistent with the diagnostic
criteria for leptospirosis, 824 (81.1%) were male and 730 (71.9%) men
older than 17 years. After excluding females and patients with missing
values, the sample was restricted to 442 patients. Among these 442
patients, 180 (40.7%) were in the hypoK, 245 (55.4%) in the normoK
and 17 (3.8%) in the hyperK group (Table 1). In the total group the
mean age was 36.8 ± 13.4 years (median = 34 years) and 16.7% were
³ 50 years. The mean age was significantly higher for the hyperK group
(p < 0.05). Icterus at hospital admission was observed in 413 of 435
(94.9%) patients with similar frequency across the potassium groups
(p > 0.1). Intravenous penicillin was administered for 78.7% of the
patients. The proportion of patients treated by penicillin was smaller in
the hyperK group (70.6), than in the hypoK (81.7%) and the normoK
(77.1%) groups (p > 0.1). The mean of the initial serum creatinine was
4.6 ± 2.6mg/dl in the total group and significantly (p < 0.05) higher for
the hyperK group (7.8 ± 3.5 mg/dl). The mean of symptom duration was
6.1 ± 2.5 days for the whole group and marginally significantly (p = 0.066)
higher in the hyperK group (7.4 ± 2.8 days). Duration of symptoms was
significantly (p < 0.05) shorter (5.8 ± 2.4 versus 7.4 ± 2.4 days) among
patients treated by penicillin (data not shown in the table).
As shown in Table 2, the in-hospital case-fatality rate was 14.5%
(64/442). The percent of death was significantly higher (p < 0.05) in
patients with ages ³ 50 (35.1%, 26/74) as compared with those with
ages below 50 years (10.3%, 38/368). Serum creatinine was also
significantly (p < 0.05) associated with death. None of the 42 patients
with creatinine below 1.5 mg/dl died. The percent of death was 4.1%
Table 1
Characteristics of the patients
Serum Potassium Groups (mEq/l)
hypoK (<3.5) normoK (3.5-5.0) hyperK (>5.0) Total
N = 180 N = 245 N = 17 442
Age (years)
mean±SD 36.5 ± 11.5 36.1 ± 13.8 50.6 ± 19.5** 36.8 ± 13.4
median 35.0 34.0 46.0 34.0
% Jaundice (N)* 95.5 (170/178) 94.2 (226/240) 100 (17/17) 94.9 (413/435)
% Received Penicillin (N) 81.7 (147/180) 77.1 (189/245) 70.6 (12/17) 78.7 (348/442)
Creatinine (mg/dl)
mean±SD 4.2 ± 2.2 4.6 ± 2.6 7.8 ± 3.5** 4.6 ± 2.6
median 3.9 4.3 8.3 4.2
Symptoms (days)
mean±SD 6.0 ± 2.0 6.2 ± 2.7 7.4 ± 2.8*** 6.1 ± 2.5
median 6.0 6.0 8.0 6
* Data on icterus were missing for 7 (2 in the hypoK and 5 in the normoK groups); ** p = < 0.05; *** p = 0.066
Table 2
Crude and logistic-regression adjusted associations between
potassium and death
Potassium Groups Death* % Odds Ratio (95% Confidence Interval)
(mEq/l) yes no Death* crude adjusted**
hypoK (<3.5) 20 160 11.1 0.73 (0.40-1.30) 0.80 (0.43-1.49)
normoK (3.5-5) 36 209 14.7 reference = 1 reference = 1
hyperK (>5) 8 9 47.1 5.16 (1.87-14.25)*** 3.95 (1.23-12.66)****
Total 64 378 14.5
* p for trend in death across the serum potassium groups = 0.005; ** adjusted for age, creatinine level and duration of symptoms; *** p = 0.002; **** p = 0.021
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(4/98) and 19.9% (60/302) in the creatinine groups 1.5-3 and >3 mg/dl
groups, respectively. The case-fatality rate was lower in the group
admitted with less than four days of symptoms (9.3%, 4/43) than in the
groups with 4-6 (15.9%, 35/220) and ³ 7 days (14.0%, 25/179). These
differences, however, were not statistically significant (p > 0.1). The
case-fatality rate was also lower, although statistically not significant
(p > 0.1), in the anicteric (4.5%, 1/22) than in the icteric group (14.8%,
61/413). These death data by age, creatinine and symptom duration are
not shown in the table.
The case-fatality rate of leptospirosis increased significantly (p for
trend < 0.05) with the initial level of serum K+: 11.1% (20/180), 14.7%
(36/245) and 47.1% (8/17) in the hypoK, normoK and hyperK groups,
respectively (Table 2). The crude odds of death were more than 5 times
higher (odds ratio (OR) = 5.16; 95% CI = 1.87-14.25; p = 0.002) in the
hyperK as compared with the normoK group. This association between
increased serum K+ and increased mortality remained statistically
significant after adjustment for serum creatinine value, age and duration
of symptoms. The adjusted odds of death were almost four times higher
(OR = 3.95; 95% CI = 1.23-12.66; p = 0.021) in the hyperK than in the
normoK group.
DISCUSSION
This study expands our knowledge about serum potassium and its
relation to in-hospital case-fatality rate of leptospirosis. In this sample,
hypokalemia (K+ < 3.5 mEq/l) was found in approximately 41% of men,
confirming that it is a very common finding in leptospirosis. SEGURO et
al.13, in São Paulo, studying 56 patients with leptospirosis found
hypokalemia in 45%, a very similar finding to those of the present study.
Unfortunately, it was not possible to correlate potassium level with the
urinary output. According to previous observations, however, the low
frequency of hyperkalemia in patients with ARF due to leptospirosis
(compared to other causes of ARF) is partly explained by the high frequency
of nonoliguric ARF12,13. Another factor that can contribute to hypokalemia
in leptospirosis is the inhibition of Na, K-ATPase activity in the renal
proximal tubules. This alteration causes an increased distal sodium delivery
and consequently an increase in potassium secretion13,15.
The in-hospital case-fatality rate of leptospirosis was positively and
significantly associated with the initial serum potassium value. The crude
odds of death for patients in the hyperK were significantly higher, over
fivefold, than the odds in the normoK group. It should be noted that,
compared with normal values of potassium, hypokalemia was not
associated with increased risk of death. One potential explanation for
this finding is that hypokalemia is an easily treatable alteration. It is also
worth noting that the patients of the hypoK and the normoK groups had,
on average, lower duration of symptoms than the patients of the hyperK
group. A shorter interval between the start of clinically manifested disease
and the introduction of the treatment for leptospirosis could also have
contributed to a lower death rate observed in the hypoK and normoK
groups. It important to note that the proportion of patients treated by
penicillin was smaller (although not significantly different) in the hyperK
group. Moreover, patients treated by penicillin had a significantly lower
duration of symptoms at admission. These data are consistent with the
lack of scientific evidence that the introduction of antibiotics at the late
stage of leptospirosis reduces the risk of death. It is plausible to
hypothesize that the hypoK and the normoK groups are comprised of
patients to whom we have more to offer to prevent death as compared to
the hyperK group.
In addition to a higher duration of symptoms, patients on the hyperK
group were, on average, older and had higher levels of serum creatinine.
According to the logistic regression analysis, however, the higher risk
of death in the hyperK cannot be fully explained by differences in age,
renal function and duration of symptoms. In addition to the delay to
initiate specific treatment interventions for leptospirosis other potential
explanations for the higher risk of death in the hyperK group are
congestive heart failure in oliguric and anuric patients and a variety of
metabolic alterations associated with hyperkalemia that may contribute
to tissue lesion, e.g., metabolic acidosis. The influence of these potential
explanatory factors on the association between serum potassium and
case-fatality rate of leptospirosis was not assessed in this study and should
be viewed as an important questions for future research
Because of the retrospective nature of the study, data on disease
outcome and laboratory exams, including the macroscopic slide test, of
several patients could not be found. The absence of information on the
serologic tests may raise questions about the possibility of misclassification
on the diagnosis of leptospirosis with certain diseases, particularly dengue
and hantavirus. It is unlikely, however, that diagnostic misclassification
with dengue have affected significantly the results, considering that more
than 90 percent of the patients were icteric and a large fraction had renal
failure, manifestations typical of Weil’s disease6. It should be observed,
that according to the existent data, hantavirus is present in Salvador but
symptomatic disease is likely a very rare condition in patients hospitalized
at HCMaia14. The fact that this study was restricted to men limits
generalization of the finding to women. This restriction took into account,
primarily, the validity of the study. The number of women with reported
data on the variables of interest was small. In addition, there was a concern
of a differential contribution of the muscle mass to determine specific
levels of serum potassium and serum creatinine between males and females
with leptospirosis. Studies including larger number of women with
leptospirosis are needed to permit valid estimates of the association between
levels of potassium and risk of death in this group.
In conclusion, these data suggest that the initial serum potassium
value is positively associated with in-hospital case-fatality rate of
leptospirosis in men. This association could not be fully explained by
differences in age, serum creatinine and duration of symptoms. Although
the study was not designed to assess the effect of treatment on mortality,
it calls attention to the need for implementation of strategies aimed at
identifying patients with leptospirosis at early stage of the disease when
the treatment is more effective. It is expected that this kind of intervention
will reduce the risk of severe complications of leptospirosis, including
hyperkalemia and its associated higher risk of death.
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RESUMO
Associação entre potássio sérico na admissão hospitalar e
letalidade da leptospirose em homens
Leptospirose grave afeta predominantemente os homens e apresenta
alta susceptibilidade para insuficiência renal aguda com hipocalemia.
Como hipocalemia e hipercalemia induzem complicações graves, é
importante avaliar se o potássio sérico é um independente fator de risco
de morte na leptospirose. Foram revistos os prontuários de 1016 pacientes
internados com o diagnóstico de leptospirose. A análise foi restrita a
442, obedecendo os seguintes critérios: sexo masculino, idade igual ou
superior a 18 anos, informação sobre morte ou alta hospitalar e registro
dos valores do potássio sérico, da creatinina sérica e da duração dos
sintomas. Valores de potássio menor do que 3,5 mEq/l (hipoK),
3,5-5 mEq/L (normoK) e superior a 5 mEq/L (hiperK) foram detectados
em 180, 245 e 17 pacientes, respectivamente. A mortalidade aumentou
com a elevação do potássio: 11,1% no grupo hipoK, 14,7% no normoK
e 47,1% no hiperK (p = 0,002). Em um modelo de regressão logística
(normoK como referência), incluindo idade, creatinina e duração de
sintomas, hipoK não se associou com aumento da mortalidade (odds
ratio (OR) = 0,72; p > 0,1). Contrariamente, hiperK foi significantemente
associado com risco aumentado de morte (OR = 3,95; p = 0,021). Em
conclusão, nesta amostra de homens com leptospirose o potássio sérico
inicial foi positivamente e independentemente correlacionado com risco
de morte hospitalar.
REFERENCES
1. ABDULKADER, R.C.; SEGURO, A.C.; MALHEIRO, P.S.; BURDMANN, E.A. &
MARCONDES, M. - Peculiar electrolytic and hormonal abnormalities in acute renal
failure due to leptospirosis. Amer. J. trop. Med. Hyg., 54: 1-6, 1996.
2. CICERONI, L.; PINTO, A.; BENEDETTI, E. et al. - Human leptospirosis in Italy, 1986-
1993. Europ. J. Epidem., 11: 707-710, 1995.
3. DAHER, E.; ZANETTA, D.M.; CAVALCANTE, M.B. & ABDULKADER, R.C. - Risk
factors for death and changing patterns in leptospirosis acute renal failure. Amer. J.
trop. Med. Hyg., 61: 630-634, 1999.
4. DAVILA DE ARRIAGA, A.J.; ROCHA, A.S.; YASUDA, P.H. & DE BRITO, T. - Morpho-
functional patterns of kidney injury in the experimental leptospirosis of the guinea-
pig (L. icterohaemorrhagiae). J. Path., 138: 145-161, 1982.
5. DUPONT, H.; DUPONT PERDRIZET, D.; PERIE, J.L. et al. - Leptospirosis: prognostic
factors associated with mortality. Clin. infect. Dis., 25: 720-724, 1997.
6. FAINE, S. - Guidelines for the control of leptospirosis. Wld. Hlth. Org. Offset Publ.,
67: 1-171, 1982.
7. FARR, R.W. - Leptospirosis. Clin. infect. Dis., 21: 1-6, 1995.
8. GAHLINGER, P.M. & ABRAMSON, J.H. - Computer Programs for Epidemiologists:
PEPI Version 3. Stone Mountain, GA, 1999.
9. KO, A.I.; GALVÃO REIS, M.; RIBEIRO DOURADO, C.M.; JOHNSON JR, W.D. &
RILEY, L.W. - Urban epidemic of severe leptospirosis in Brazil. Salvador
Leptospirosis Study Group. Lancet, 354: 820-825, 1999.
10. NORUSIS, M.J. - SPSS for Windows: advanced Statistics, release 6.0. Chicago, SPSS
Inc., 1993.
11. NORUSIS, M.J. - SPSS for Windows: base system user’s guide, release 6.0. Chicago,
SPPS Inc., 1993.
12. RAMACHANDRAN, S.; RAJAPAKSE, C.N.; PERERA, M.V. & YOGANATHAN, M.
- Patterns of acute renal failure in leptospirosis. J. trop. Med. Hyg., 79: 158-160,
1976.
13. SEGURO, A.C.; LOMAR, A.V. & ROCHA, A.S. - Acute renal failure of leptospirosis:
nonoliguric and hypokalemic forms. Nephron, 55: 146-151, 1990.
14. TRAVASSOS DA ROSA, E.S.; VASCONCELOS, P.F.C.; TAVARES-NETO, J. et al. -
Prevalence of antibodies to hantaviruses in Salvador, Bahia, Brazil. In: CONGRESSO
DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 31., Brasilia, 1995.
Resumos. p. 185
15. YOUNES-IBRAHIM, M.; BURTH, P.; FARIA, M.V. et al. - Inhibition of Na,K-ATPase
by an endotoxin extracted from Leptospira interrogans: a possible mechanism for
the physiopathology of leptospirosis. C. R. Acad. Sci. (Paris), 318: 619-625, 1995.
Received: 27 December 2000
Accepted: 10 July 2001
